Perceptions and Representations of Cancer Chemotherapy

NCT ID: NCT02851160

Last Updated: 2016-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care. Framework type of method using grounded theory

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory.

The objective of the research:

To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.

To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients requiring lung cancer chemotherapy

30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment having a semi-structured interview conducted by a clinical psychologist

semi-structured interview conducted by a clinical psychologist

Intervention Type OTHER

semi-structured interview conducted by a clinical psychologist

Family of lung cancer patients receiving chemotherapy

30 Family of lung cancer patients receiving chemotherapy having a semi-structured interview conducted by a clinical psychologist

semi-structured interview conducted by a clinical psychologist

Intervention Type OTHER

semi-structured interview conducted by a clinical psychologist

doctors caring for lung cancer patients receiving chemotherapy

15 doctors caring for lung cancer patients receiving chemotherapy 15 have a semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

Intervention Type OTHER

semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

semi-structured interview conducted by a clinical psychologist

semi-structured interview conducted by a clinical psychologist

Intervention Type OTHER

semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
* 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
* 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Exclusion Criteria

* NA
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL16_0208

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutrition and Chemotherapy
NCT03840213 UNKNOWN